News and events

Joyce Tait delivers keynote presentation at Bloomsbury SET conference

18 March 2021

Innogen co-director Joyce Tait gave a keynote presentation at the virtual Bloomsbury SET conference focused on infectious diseases and antimicrobial resistance. Her talk in the first session of the conference: “Interdisciplinary knowledge exchange to tackle global health challenges” highlighted some of the Innogen’s work on regulatory adaptation to support the development of new antimicrobial drugs and rapid diagnostics.

Industry-wide standard supports companies to innovate responsibly

4 February 2021

Innogen Masters students trial the application of the British Standards Institution (BSI) Responsible Innovation Guide, PAS 440, in two early-stage biotechnology companies.

Innogen researchers speak out about the value and fair diffusion of COVID-19 vaccines

21 January 2021

Innogen researchers have been featured in national and international media outlets addressing some of the questions that the vaccine roll-out has raised.

PAS 440 — Responsible Innovation in the spotlight

15 December 2020

In the latest episode of the BSI EDUCATION PODCAST, Joyce Tait, technical author of the standard PAS 440 explains how it was developed and its relevance for regulatory adaptation in the UK.

In Conversation event: Are innovation policies ever value neutral?

16 November 2020

Smita Srinivas & Theo Papaioannou in conversation with David Wield discuss innovation as a political process of development in the context of COVID-19.

Rapid diagnostic tests are no panacea for tackling antimicrobial resistance

5 November 2020

Innogen members Ann Bruce and Katie Adam have co-authored a paper as part of the Diagnostic Innovation and Livestock (DIAL) project team, in collaboration with the University of Exeter and Bristol Veterinary School. This new publication explores the potential role of rapid or point-of-care diagnostic tests for farm animals in supporting decisions about antimicrobial use in livestock.

European funding boosts production of animal feed made from recycled carbon

29 October 2020

Innogen researchers are working on a recycling project with Deep Branch Biotechnology that produces sustainable protein for animal feed from carbon dioxide. The company has recently secured European Innovation Council (EIC) Accelerator funding of €2.5 million to scale up production.

National COVID-19 testing strategy analysis

15 October 2020

Innogen member Smita Srinivas and co-authors analyse COVID-19 testing in different countries. They highlight the need to take the industrial organisation of health systems within countries into account for testing strategies to be successful.

Predicting COVID-19 vaccine success

8 October 2020

Innogen Associate, Dr Jack Scannell, has co-authored a policy paper for the Centre for Global Development that analyses the COVID-19 vaccine pipeline. This work aims to bring high-quality probabilistic models of the COVID-19 vaccine pipeline into the public domain, to help policy development as well as the management of technological and manufacturing risks.  

Interview with Prof. Chris Warkup on R&D in the UK

6 October 2020

We speak with Chris Warkup, Visiting Professor, Innogen Institute, The Open University, about the actions that are required to develop the UK Government’s Research and Development (R&D) Roadmap and realise the UK’s ambition for science, research and innovation. Chris gives some answers to the Government’s consultation questions based on his career at the interface of academia, industry, policy makers, funders and investors.